Skip to content

Prayer in Commbate to Corona Virus - Covid -19

A Double Blind, Controlled, Randomized, Prospective Study That Will Evaluate the Impact of Remote Intercession Prayer on the Clinical Evolution of Patients Diagnosed With COVID -19 in HCOR.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04631380
Enrollment
200
Registered
2020-11-17
Start date
2020-08-01
Completion date
2022-01-01
Last updated
2022-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

PATIENTS WHO ARE ADMITTED TO HOSPITALIZATION IN HCOR AND WHO HAVE THE CONFIRMED DIAGNOSIS OF CORONA VIRUS, WILL BE ASKED TO CONSENT TO PARTICIPATE IN THIS STUDY THAT INTENDS TO STUDY THE EFFECTIVENESS OF THE REMOTE INTERCESSION PRAYER IN COMBATING THIS DISEASE.

Detailed description

PATIENTS WHO AGREE TO PARTICIPATE IN THE STUDY WILL BE SEPARATED INTO 2 GROUPS, THE INTERVENTION GROUP AND THE CONTROL GROUP. THE IDENTITY OF THE PATIENTS WILL BE KEPT IN SECRET AND ONLY THEIR INITIALS WILL BE LISTED. THE INTERVENTION GROUP WILL RECEIVE DAILY PRAYERS AND THE EVOLUTIONARY CLINICAL RESULTS OF THE TWO GROUPS WILL BE PURCHASED.

Interventions

OTHERPRAYER

THE PRAYER GROUP WILL RECEIVE ABSOLUTELY THE SAME CARE AS THE CONTROL GROUP PLUS PRAYERS

Sponsors

Hospital do Coracao
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

RAMDOMIZED DOBLE-BLINDING

Intervention model description

PROSPECTIVE RANDOMIZED DOUBLE-BLIND STUDY

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients hospitalized in comun hospital rooms and intensive care units with confirmed COVID-19.

Exclusion criteria

* Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization * Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization. * Patients 18 years of age or older * Patients with indication of palliative care and definition of terminality at hospital admission * Patients who voluntarily choose not to participate in the study at the time of the • presentation of the Informed Consent Form.

Design outcomes

Primary

MeasureTime frameDescription
DEATH OR RECOVERY60 DAYSWE WILL EVALUATE DEATHS OR HOSPITAL DISCHARGE

Secondary

MeasureTime frameDescription
NEED FOR MECHANICAL VENTILATION60 DAYSNEED FOR MECHANICAL VENTILATION
TIME OF REMAINED INTUBATED60 DAYSTIME OF REMAINED INTUBATED
LENGTH OF STAY IN ICU60 DAYSLENGTH OF STAY IN ICU
TIME OF STAY HOSPITALIZED60 DAYSTIME OF STAY HOSPITALIZED
Occurrence of clinical complications.60 DAYSOccurrence of clinical complications that were not included before diagnostic confirmation and that may be related to covid infection.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026